Scientific leader for ViiV Healthcare writing in glass


When considering the heritage from our founding companies, we can proudly say that we have been involved in the development of effective treatments for HIV/AIDS from the beginning.

Not only are we continuing to explore new ways to treat, prevent, and ultimately find a cure for HIV, we are also focusing on understanding how we can bridge the gap between research and everyday clinical practice through implementation science and patient centred studies.

We support a growing community of researchers, policy makers, community organisations, advocates and other stakeholders who are interested in studying current HIV care practices.

Our aim is to challenge the status quo, and shape health policy and practices that can lead to an HIV-free future.

Find out all about current HIV clinical trials and studies, why diversity is important in clinical trials, how they’re regulated and how to get involved.

The needs of people living with HIV change over time, and we‘re exploring new ways of treating and preventing HIV through new mechanisms of action and drug delivery.

The process of identifying, creating and developing generally well-tolerated and effective innovative HIV therapies is complex and requires ongoing collaboration between research teams that work in many different areas of medicines development.


View all science and innovation articles

Discover how we work with leading researchers and academic groups to innovate and bring the best science to HIV treatment, prevention and care...

To lift the substantial burdens of daily treatment and social stigma associated with HIV, a cure is essential towards accomplishing our goal of ending the HIV epidemic. With this goal in mind, we are in pursuit of a cure for HIV. 

We’ve got more than 50 active collaborations worldwide with pharmaceutical and biotechnology companies, government agencies, academic institutions and not-for-profit organisations to broaden our capabilities and enhance our performance. 

With significant progress made in the fight against HIV, how do we make sure that clinically proven tools are implemented into real-world settings?

NP-GBL-HVX-COCO-220018 April 2024

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.